CAR-T Cell Therapy

CAR-T cell therapy is an advanced form of immunotherapy that leverages the patient’s own immune system to fight blood cancers like leukemia and lymphoma. This therapy involves collecting T-cells from the patient, genetically modifying them to express Chimeric Antigen Receptors (CARs) that can specifically target cancer cells, expanding these modified cells in the lab, and then reinfusing them into the patient. This personalized approach provides targeted cancer treatment with potential long-lasting effects, though challenges such as high costs, complex manufacturing, and severe side effects remain. Ongoing research aims to improve the therapy's efficacy and accessibility.